Evaluation of Benefit and Tolerability of IQP‐CL‐101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double‐Blinded, Randomised, Placebo‐Controlled Clinical Trial

Irritable bowel syndrome (IBS) is a functional bowel disorder of unknown aetiology. There is currently no known cure, and pharmacological interventions are usually targeting symptomatic relief, where natural and herbal remedies also play a role. This study aimed to evaluate the benefit and tolerabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Alt, Felix, Chong, Pee‐Win, Teng, Emily, Uebelhack, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518189/
https://www.ncbi.nlm.nih.gov/pubmed/28508427
http://dx.doi.org/10.1002/ptr.5826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518189/
https://www.ncbi.nlm.nih.gov/pubmed/28508427
http://dx.doi.org/10.1002/ptr.5826

Ejemplares similares